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Abstract
Background: Multimodal protocols of perioperative care may enhance postoperative recovery. However, limited
information is available on preoperative immune and carbohydrate (CHO)-enriched drinks in patients undergoing
hip arthroplasty. We aimed to investigate the effect of a multimodal protocol (ACERTO protocol) plus preoperative
immune nutrition on the length of stay (LOS) and the postoperative acute phase response of patients undergoing
total hip arthroplasty.
Methods: Thirty-two patients (mean age, 58 years; range, 26–85 years; 16 males) were randomized to receive either the
ACERTO protocol (n= 15, ACERTO Group), which consisted of 6 h preoperative fasting for solids, an oral drink (200 mL of
12.5 % maltodextrin) up to 2 h before induction of anesthesia, restricted intravenous fluids (only 1000 mL of crystalloid
fluid after surgery) and preoperative immune nutrition (600 mL/day of Impact - Nestlé, Brazil) for five days prior to surgery,
or traditional care (n = 17; control group), which consisted of 6–8 h preoperative fasting, intravenous hydration until the
1st postoperative day and no preoperative immune supplementation. The main endpoint was LOS. C-reactive protein
(CRP) was the secondary endpoint and was assessed during induction of anesthesia and on postoperative day 2.
Results: Neither deaths nor postoperative complications occurred. The median LOS was 3 (2–5) days in the ACERTO
group and 6 (3–8) days in controls (P <0.01). Postoperative CRP was higher in the control group (P <0.01).
Conclusion: The ACERTO multimodal protocol of perioperative care plus preoperative immune nutrition may decrease
LOS and postoperative CRP levels in total hip arthroplasty.
Trial registration: Clinical Trials: NCT02580214
Keywords: Total hip arthroplasty, Perioperative care, C-reactive protein, Preoperative fasting, Immune nutrition, Length of
hospital stay
Background
Total hip arthroplasty (THA) is a common orthopedic
procedure and may improve long-term quality of life for
many patients. More than 70,000 THA are performed
each year in UK [1]. In the USA it is estimated that
nearly 500,000 THA are performed each year [2] and
that the demand for primary THA will increase by
174 % by the year 2030 [3]. As the hospital costs are
high, solutions for decreasing complications and length
of stay are demanded.
A review of the evidence has shown that traditional
perioperative care has a weak scientific basis and needs
to be changed [4]. Multimodal or fast-track protocols of
perioperative care for abdominal surgery have been asso-
ciated with lower morbidity, lower costs and faster post-
operative recovery than traditional care [5]. Similarly,
the use of oral supplements containing immune nutri-
ents such as arginine and omega-3 fatty acids for 5–7
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days before major abdominal surgery may decrease the
risk of infection and reduce postoperative length of stay
(LOS) [6]. Of note, studies of the effect of multimodal
protocols, including immune nutrition, on postoperative
recovery from elective THA are lacking [7]. Probable
barriers to implementation involve multiple care disci-
plines [8]. Although the outcome after THA has im-
proved over time, in parallel with the development of
improved surgical techniques and pain control, we as-
sume that the use of a multimodal protocol that includes
preoperative immune nutrition may enhance postopera-
tive recovery [9]. In Brazil, the ACERTO (an acronym in
Portuguese for acceleration of postoperative recovery)
protocol is a multimodal protocol of perioperative care
that includes shorter preoperative fasting with carbohy-
drates (CHO)-rich drinks up to 2 h before surgery,
restriction of intravenous fluids, early postoperative feed-
ing and early mobilization [10, 11]. Recently, the multi-
modal ACERTO protocol added a recommendation of
perioperative immune nutrition. All the elements of the
protocol are evidence-based and are recommended by
several international guidelines and consensus panels.
Thus, the aim of this pilot study was to investigate
whether the use of the ACERTO multimodal protocol
plus preoperative immune nutrition would decrease the
LOS and acute phase inflammation in patients who
undergo THA.
Methods
This was a prospective, randomized pilot study. All pro-
cedures were performed at the São Mateus Hospital
(Cuiabá, Brazil) from May 2012 to February 2013. The
study was approved by the Research Ethics Committee
of the Júlio Müller University Hospital (Federal Univer-
sity of Mato Grosso) and all patients signed an informed
consent form. The trial was registered at Clinicaltrial-
s.org with the number NCT02580214.
Inclusion and exclusion criteria
We included adult patients (18–80 y/o) of both sexes
who had hip osteoarthrosis and were candidates for
elective THA. Patients were excluded if they had fasting
glycemia measurements >200 mg/dL; acquired immuno-
deficiency; renal failure (creatinine >2 mg/dL); cirrhosis;
moderate or severe Alzheimer's disease (clinical demen-
tia rating score between 2 and 3); an American Society
of Anesthesiologists (ASA) score >2; previous spinal sur-
gery (arthrodesis) or previous THA (reviewing or chan-
ging the prostheses); or severe malnutrition (loss of 10 %
of body weight over the last 6 months). We also ex-
cluded patients whose blood samples were not obtained
at the scheduled time or who did not complete the peri-
operative protocol, e.g., did not consume the immune
supplement if assigned to the ACERTO group.
Study design
Patients were enrolled consecutively and randomized
into two groups, control group and ACERTO group,
using electronically generated random numbers available
at www.graphpad.com. The main differences between
the two groups in perioperative care are displayed in
Table 1. Not only the surgeon but a multidisciplinary
Table 1 Comparison of the perioperative care of the two study groups






6–8 h fast prior to surgery. 6–8 h fast for solids; carbohydrate drink (12 % maltodextrin),
200 mL up to 2 h before surgery.
Preoperative
nutrition
None Immune supplement 600 mL/day for 5 days prior to surgery
Anesthesia: Spinal blockage Spinal blockage
Antibiotic
prophylaxis:
Kefazolin: 2 g during anesthesia induction followed by
1 g every 8 h for 48 h.
Kefazolin: 2 g during anesthesia induction followed by 1 g every
8 h for 48 h.
Drains and
catheters:
Not used Not used.
Intravenous
fluids:
Intra-operative: 5 to 10 mL of crystalloids/kg/h. Postoperative
course: 0.9 % saline solution, 30 to 40 mL/kg/day, until the 2nd
postoperative day.
Intra-operative: 5 to 10 mL of crystalloids/kg/h. Postoperative




20 mg of enoxaparin immediately post-operative (6 h after
anesthetic block) and 40 mg/day from the 1st until the 35th post-
operative day. Use of medium leg compression stockings
20 mg of enoxaparin immediately post-operative (6 h after
anesthetic block) and 40 mg/day from the 1st until the 35th post-
operative day. Use of medium leg compression stockings
Early
feeding:
Diet at will starting 6 h after surgery Diet at will starting 2–4 h after surgery
Mobilization: Sit up and walk on the 1st postoperative day. Sit up and walk the same day as surgery.
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team saw all patients before the THA: a dietitian
assessed anthropometric data and confirm the nutrition
status, a nurse gave preoperative counseling and the
anesthetist performed preoperative visit.
Anesthesia and operative techniques
For antibiotic prophylaxis, 2 g of intravenous kefazolin
was administered at the time of anesthesia induction.
For preoperative, sedation intravenous midazolam (0.03
to 0.1 mg/kg) and propofol (30 to 60 mcg/kg/min) were
given. Neither group received general anesthesia. All
subjects received epidural neuro-axis blockage at the
L3-L4 space with ropivacain 7.5 to 10 % (150–200 mg)
and morphine chlorate 2 mg (30 to 50 micrograms/kg).
The hip was accessed surgically using an anterior-
lateral approach. For all patients, we used a hybrid type
of prosthesis for total arthroplasty (cementation of the
femoral component and fixation of the acetabular com-
ponent by means of pressure fitting of the implant to
the bone and the addition of screws to the acetabular
cup when necessary).
Carbohydrate drink
Patients belonging to the ACERTO group received a
drink (200 mL) containing water plus 12 % maltodextrin
2 h before the induction of anesthesia.
Immune supplementation therapy
The patients in the ACERTO group received an immune
supplement containing arginine, ω-3 fatty acids, nucleo-
tides and vitamins (Impact; Nestlé; Sao Paulo, Brazil).
Formula: proteins: 23 % (77 % calcium caseinate, 23 %
arginine); carbohydrates: 52 % (100 % maltodextrin);
lipids: 25 % (68 % fish oil; 20 % medium-chain triglycer-
ides and 12 % corn oil), vitamins and electrolytes for five
days prior to surgery, with a daily dosage of three
200 mL drinks (600 mL per day in total).
Blood samples
Blood samples were collected preoperatively at anesthesia
induction and on the 2nd postoperative day and assayed
for CRP.
Criteria for hospital discharge
Discharge was ordered by an orthopedic surgeon if all
five of the following conditions were met: 1) patient is
confident and willing to go home, 2) no pain or pain
controlled by oral analgesics, 3) walking alone or with
minimal help, 4) no fever or signs of postoperative in-
fection and 5) accepting normal oral diet.
Outcome variables
The main outcome variable was the postoperative LOS.
As a secondary outcome variable we compared the evo-
lution of serum C-reactive protein over time.
Statistical analysis
The calculation of the sample size was based on the
premise that the intervention with the ACERTO Project
protocol would reduce the hospital LOS by 50 %. As-
suming a β error (type II) of 20 % and a α error (type I)
of 5 %, sample size calculations indicated 15 patients per
group would be sufficient for this study. We used paired
and unpaired Student’s t-test when samples had homo-
geneous variances or the Mann-Whitney test or the
Wilcoxon test if samples had heterogeneous variances.
CRP levels obtained at two different times were com-
pared by repeated measures ANOVA. Categorical vari-
ables were compared by the chi square test or Fisher
exact test. Statistical analyses were performed using
SPSS 17.0 software and the null hypothesis rejection was
fixed at P = 0.05 (α = 5 %).
Table 2 Preoperative demographic and clinical data of the two
study groups of patients who underwent total hip arthroplasty
Variables Control Group ACERTO Group pa
(n = 17): (n = 15)
n(%) or Mean ± DP n(%) or Mean ± DP
Age (years) 58 ±17 57 ±12 0.92
Sex
Male 8 47 % 8 53 % 0.72
Female 9 53 % 7 47 %
Comorbiditiesb
Yes 10 59 % 12 80 % 0.20
No 7 41 % 3 20 %
Nutritional
Assessment
Malnourished 5 29 % 2 13 % 0.40
Eutrophic 12 71 % 13 87 %
Immune supplement
Yes 0 0 % 15 87 % <0.01
No 17 100 % 0 13 %
Fasting time (h) 9.52 ±1.54 2 ±0 <0.001
Hb (g/dL) 13.35 ±1.10 12.95 ±1.39 0.38
CRP (g/L) 10.24 ±5.09 10.13 ±6.38 0.96
SD standard deviation; n number of patients; VHS velocity of hemo- sedimentation;
CRP C-reactive protein; Hb hemoglobin
aChi square, Fisher Exact Test and Wilcoxon t test
bDiabetes mellitus, arterial hypertension, or chronic obstructive
pulmonary disease
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Results
The demographic and clinical characteristics of the two
groups are displayed in Table 2 and indicated homogen-
eity between the two groups. Mean body mass index was
27 (20–31 kg/m2) without difference between groups.
The flowchart of the study can be seen in Fig. 1. Forty
patients were eligible, 36 were randomized and 32 were
analyzed (15 in ACERTO group and 17 in control
group). There were no deaths. No patients experienced
bronchial-aspiration during the anesthesia induction.
The duration of the operations ranged from 80 to
125 min (mean = 107 min) for the control group and 85
to 128 min (mean = 103 min) for the ACERTO group
(P = 0.46). No patients in either group developed a
postoperative infection during 60 days of follow-up, re-
quired another surgical intervention, were re-admitted
in the hospital or require a blood transfusion in the two
groups. The ACERTO group received significantly less
intravenous crystalloid fluids than controls.
CRP assay
The findings of the CRP assays are displayed in in Fig. 2
and Table 3. Preoperative CRP values were similar be-
tween groups (ACERTO group = 10.2 [6.3] mg/L vs
Control group = 10.2 [5.1] mg/L; p > 0.05). Although
CRP values increased over time in both groups, on the
2nd postoperative day, they were greater in the controls
than in the ACERTO group (80.6 [10.9] vs 66.5 [16.4]
mg/L, p < 0.01).
Length of stay
The patients of the ACERTO group (median = 3 days,
range 2–5 days) stayed a median of 3 days less (p < 0.01)
than the controls (median = 6 days, range 3–8 days).
Figure 3 shows the LOS of each individual in the
two groups.
Discussion
This study’s findings show that the use of the ACERTO
protocol plus preoperative immune nutrition was advan-
tageous for these patients who underwent elective THA.
For ACERTO group, the increase of postoperative CRP
levels was mild and the patients in this group were dis-
charged earlier. Although this is a pilot study with a
small number of patients, the two groups were similar,
implying that these findings are reliable. Moreover, the
surgical team, the type of operation, the prosthetic
device, and the hospital were always the same, which im-
plies internal validity of this comparison.
No other study in Brazil has investigated the modern
precepts of the ACERTO project (shortened fasting,
Fig. 1 Flowchart of the study
Fig. 2 Preoperative and postoperative C-reactive protein (CRP) values in the 2 study groups. Each bars depicts the mean and SD of the CRP values. *,
p < 0.05 postoperative versus preoperative CRP values (repeated measures ANOVA). †, P < 0.01 control versus ACERTO group, Student’s T Test
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restriction of perioperative hydration, early mobilization
and preoperative immune nutrition) for elective THA.
Our findings suggest that the ACERTO protocol is safe
for THA patients and does not increase the risk of
bronchial aspiration during anesthesia induction, which
is relevant for other types of surgeries [4, 12]. There-
fore, the main implication of the findings of this pilot
study is the urgent need for more study of the
ACERTO protocol in orthopedic surgery because the
protocol seems safe, reproducible and beneficial to pa-
tients undergoing elective THA.
The prescription of an overnight preoperative fasting
is very common. However, the evidence behind this trad-
itional protocol is weak [13]. The actual length of post-
operative fasting may be greater than prescribed, which
results in fasting times greater than 12 h [14]. Substan-
tial evidence has shown that a 6–8 h fast for solids and
2–3 h for carbohydrate drink is safe and recommended
by several societies of anesthesiologists [15, 16]. Pro-
longed preoperative fasting initiates a metabolic re-
sponse that may increase the organic response to trauma
resulting in increased insulin resistance [17]. The
metabolic effect of prolonged fasting and trauma may
impair the recovery of surgical patients [18]. Some stud-
ies of abdominal surgery have shown that the postopera-
tive LOS may be reduced by shortening preoperative
fasting [19]. Our findings agree with this recent litera-
ture; we did not observe anesthetic complications, and
the ACERTO group recovered faster.
THA patients frequently have minor to mild preopera-
tive inflammation depending on the type of joint disease.
After surgery, inflammatory markers such as CRP and
procalcitonin increase due to the acute-phase response
to trauma. CRP is one of the best biochemical markers
for detecting the postoperative inflammatory systemic
syndrome after abdominal surgery [20]. CRP has an ad-
vantage over procalcitonin; it is less expensive. CRP is
also used to monitor the postoperative course of surgical
trauma following orthopedic implants and to detect
prosthetic infection [21]. Postoperative recovery in
orthopedic surgery is directly associated with the magni-
tude of CRP or other acute-phase mediators; the lower
the CRP levels the faster postoperative recovery [22].
The lower CRP postoperative values of the ACERTO
group were probably due to several components of the
multimodal protocol, such as the shorter period of pre-
operative fasting [23, 24] and the use of a preoperative
immune enhancing supplement [25, 26]. Immune sup-
plements containing arginine, omega-3 fatty acids and
nucleotides may improve wound healing and decrease
inflammation postoperatively and are currently recom-
mended for major abdominal operations [27]. Unfortu-
nately, we have not found reports of randomized trials
of the use of preoperative immune nutrition in THA
surgery. Thus, these new data provide a relevant contri-
bution to the orthopedic surgery literature; conse-
quently, further studies are warranted.
Early postoperative feeding after surgery is safe and as-
sociated with rapid recovery. However, most of the
Table 3 Comparison of laboratory results in the two study
groups by time period
Variable Control group ACERTO group P*
Mean ± SD Median Mean ± SD Median
Hemoglogin (9/dL)
Preoperative 13.3 ± 1.1 13.5 12.9 ± 1.4 13.0 0.38
2nd PO day 10.3 ± 1.1 10.2 10.2 ± 1.2 10.2 0.78
CRP (mg/L)
Preoperative 10.2 ± 5.1 8 10.1 ± 6.4 8 0.96
2nd PO day 80.6 ± 10.9 79 66.5 ± 16.5 66 <0.01
Student’s T test
CRP C-reactive protein; SD standard deviation
* p<0.05 postoperative versus preoperative CRP values (repeated measures ANOVA)
Fig. 3 Length of postoperative stay of each patient belonging to the ACERTO group (square) and Control group (diamond). P < 0.01
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investigations on early postoperative feeding were con-
ducted after abdominal surgery [28]. Although lack of
similar randomized trials in orthopedic surgery hinders
comparisons, based on the available reports, resuming
feeding soon after surgery is safe and may decrease the
volume and duration of intravenous fluids required. On
the other hand, the maintenance of nil per os during one
or two days postoperatively seems currently unaccept-
able. The longer the postoperative fasting time the
greater the need of intravenous crystalloid therapy. Ad-
ministration of traditional volumes of intravenous crys-
talloid fluids may impair recovery and may lead to more
frequent postoperative infections [29]. Therefore, as
soon as possible, the oral route should be initiated and
intravenous therapy discontinued. The patients submit-
ted to the ACERTO protocol received less volume of
intravenous fluids, and this measure, in addition to
others, probably enhanced recovery in these patients.
The results of this study showed that patients submit-
ted to the ACERTO multimodal protocol had shorter
LOS and a smaller postoperative rise in their CRP levels.
However, because this is a pilot study with few patients,
these findings should be considered with caution. Fur-
ther randomized trials to investigate the benefits of this
protocol or other enhancing recovery protocols in either
THA or other elective orthopedic surgery are warranted.
Conclusion
The present findings allow us to conclude that the use
of the ACERTO protocol plus preoperative immune nu-
trition in elective THA may shorten the postoperative
length of hospital stay and reduce the acute-phase in-
flammatory response.
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